The European Union has put forward new legislation that would allow
generic manufacturers to make drug products with in-patent active
pharmaceutical ingredients, provided that they are intended for use
in developing countries, reports...
Dimensional Dosing Systems has received US Food and Drug
Administration (FDA) approval for over-the-counter use of the
company's insulin dosing technology in clinical trials.
According to a report, it takes 7-10 years to develop and market a
drug with costs exceeding $800 million (€625 million). This
revelation is set to add to the pressure already facing
pharmaceutical and biotechnology companies which...
Singapore-based biologics contract manufacturer, A-Bio Pharma has
won its first contract after entering into a process development
and clinical supply service agreement with GlaxoSmithKline's
vaccine division, GlaxoSmithKline...
European companies have announced hefty spending on new
manufacturing facilities this month, suggesting that despite a
difficult operating environment the pharmaceutical sector is still
prepared to make significant capital investments
Animas has entered into a license and development agreement with
Debiotech, which aims to develop the next generation of insulin
pumps and micro needles using Debiotech's Micro Electromechanical
Systems (MEMS) microfluidic technology.
A team at Purdue University in the US is developing a virtual 'data
cave' for scientific discovery that uses high-performance computing
and artificial intelligence software to display information and
interact with researchers.
Cambrex has recorded a loss in the third quarter of this year after
writing down goodwill in its biopharma division in a move that
paints a pessimistic picture of the market for outsourced
manufacturing of biological drugs.
In the wake of the expansion of the European Union with 10
additional states, attention has been fixed on the development of
the pharmaceutical industry in these and other Eastern European
states. In-Pharmatechnologist.com provides...
A report by the UK's Health and Safety Executive has concluded that
the safety of the tiny particles created by the emerging
nanotechnology industry has not been fully assessed.
Cardinal Health reported its long-delayed fourth-quarter financial
results yesterday, revealing a hike in profit and revenues for the
three months to end June, but lowered guidance for the first half
of this fiscal year.
A report focusing on the pharmaceutical and biotechnology markets
in Europe has singled out high throughput screening (HTS) as an
approach that will provide mechanistic insights and new drug leads
with improved efficiency whilst reducing...
More than half of pharmaceuticals outsourced at least 20 per cent
of their ADMET (absorption, distribution, metabolism, excretion and
toxicology) studies in 2003, according to a new market research
report looking at outsourcing in...
Novis, now with almost half a million readers, last week earned
broad industry recognition with two further publishing awards,
following on from its best publication prize earlier this year.
India is gearing up for the introduction of new legislation on
intellectual property that will bring it into line with its World
Trade Organisation commitments.
Swiss biopharmaceuticals company BioPartners has filed its first
application in Europe for a generic version of interferon alpha, a
biological drug. If approved, the 'biosimilar' could be on the
market as early as next year.
The growing loss of patent protection on blockbuster drugs over the
next few years and the rising need to contain spiralling healthcare
costs are going to lend significant impetus to the growth of
Europe's generics and biogenerics...
A marriage between US chemicals group Rockwood Specialities and
French separations specialist Novasep will create a unique company
to serve the life sciences industry, according to the two
companies.
Dutch chemicals and drugs group Akzo Nobel saw its net income
accelerate in the third quarter of this year, to the surprise of
analysts and investors, and helped by cost reductions and a big
gain from the divestment of its coatings...
Bristol-Myers Squibb has reported encouraging data from two
late-stage trials of a new drug for rheumatoid arthritis,
abatacept, the first in a new class of T cell costimulation
modulators.
This week's announcement of the US approval for an implantable
radiofrequency identification (RFID) chip for use in humans as a
prescription device has been met with consternation by a consumer
group, which fears the technology...
A study performed at Tufts University in the US, commissioned by
the Nordic Council of Ministers, has downplayed the impact of the
controversial REACH legislation on the European chemicals industry.
The US Food and Drug Administration this week approved the first
implantable radiofrequency identification microchip for human use,
elevating RFID from a tool for supply chain management into an
enabling technology for improving healthcare...
Spanish pharmaceutical company Lacer has unveiled a new investment
programme at a plant in Barcelona that will dramatically increase
its production capacity.
Serologicals has completed its acquisition of Upstate Group,
acquiring the privately held company for $205 million (€166m) in
cash ($102.5m) and stock.
The older generation is leading the consumption of nutritional
supplements in the US and the aging baby boomers are the population
to invest in, according to a new report, that also shows the
supplement industry is now firmly in the...
In-Pharmatechnologist's periodic round up of personnel moves in the
pharmaceutical sector includes a crop of new chief executives and
senior managers across the pharmachem, drug delivery and
biomanufacturing sectors.
Pharmaceutical company Mayne Pharma has entered into a unique
relationship with Birmingham's Aston University to create a
cleanroom for aseptic production that could improve the delivery of
drugs to the UK National Health Service...
Laborium Biopharma and the Biotechnology Research Institute of the
National Research Council (BRI-NRC) have entered into an alliance,
further boosting the biomanufacturing sector of Montreal in Quebec,
Canada.
AstraZeneca has suffered another disappointment in its late-stage
pipeline, with the news that the filing for approval of Galida
(tesaglitazar), its new drug for diabetes, will be delayed by the
need to carry out more studies.
Stellar Biotechnologies has been awarded $3 million (€2 million)
for the development of production methods, quality standards, and
facilities for its Keyhole Limpet Hemocyanin (KLH), a key component
of its anti-cancer vaccine.
Engineering firm AK Pharmaceuticals is to open a new Engineering
Centre of Excellence in Ireland, in a move that reaffirms the
healthy position of the Irish pharmaceutical industry. The move is
set to create 220 new jobs over the...
According to a latest report, the growth of the biotechnology
company will continue to outpace that of pharmaceutical companies,
with the seven largest biotechnology companies growing at rates
faster than the pharmaceutical industry's...
Dutch biotechnology company Crucell has initiated legal proceedings
against CEVEC Pharmaceuticals, which claims the company has
violated Crucell's PER.C6 technology's European patent.
The US Food and Drug Administration will start using a risk-based
approach for prioritising site inspections for certain
pharmaceutical products, the agency has announced in a final report
on its current good manufacturing practice...
BASF has threatened to relocate research into 'green genetic
engineering' to other countries if German law continues to restrict
R&D into plant biotechnology, with applications as diverse as
crop biomanufacturing of...
Drug maker Samaritan Pharmaceuticals, has entered into a
collaboration with Pharmaplaz to produce and supply Samiritan's
lead compound and pipeline of drugs that includes treatments for
AIDS, Alzheimer's, cancer and cardiovascular...
Franz Humer, president of the European Federation of Pharmaceutical
Industries and Associations and chief executive of Roche, has
issued a plea for a concerted effort at improving Europe's science
base at the European Parliament.
The biotech industry managed to raise almost $6 billion during the
third quarter bringing the total raised this year to $20 billion
(€16.2 billion), an increase of $3.2 billion from this time last
year, reflecting the growing confidence...
The first commercial products from chloroplast transformation
technology (CTT) looks a distinct possibility after Chlorogen
signed a joint development and supply agreement with Sigma-Aldrich
to produce four specific proteins in tobacco...
Drug delivery specialists Merrion Biopharma has announced the
opening of new facilities in Ireland, strengthening its position in
the $24 billion oral drug delivery market and reinforcing the
healthy state of the Irish pharmaceutical...
In a dispute with Stanelco Fibre Optics, Bioprogress Technology has
been awarded outright ownership of a master patent giving it
exclusive rights to the process of making capsules from
non-gelatine materials by means of radio frequency...
The European Commission has published details of a new proposed
regulation aimed at stimulating research into drugs for use in
diseases affecting children.
Chemicals group Lanxess - to be spun out of Germany's Bayer next
year - plans to relocate a plant in Texas to China in order to tap
into the strong growth in the market for chemicals there.
Medivative Technologies, a contract manufacturing and process
engineering services supplier to the life sciences and medical
device industries, has just been cleared for operations by the US
Food and Drug Administration (FDA).
A new report into pharmaceutical R&D has identified an emerging
trend favouring outsourcing of discovery research, clinical trials
and formulation manufacturing, providing pressure relief from
consistent, high-growth financial...
Ireland's pharmaceutical industry saw a return to strong growth in
July, after a lengthy period in which the prevailing wisdom was
that the sector had plateaued.